0001555280-24-000075.txt : 20240208
0001555280-24-000075.hdr.sgml : 20240208
20240208163302
ACCESSION NUMBER: 0001555280-24-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Heidi C.
CENTRAL INDEX KEY: 0001567828
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 24609594
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wk-form4_1707427970.xml
FORM 4
X0508
4
2024-02-06
0
0001555280
Zoetis Inc.
ZTS
0001567828
Chen Heidi C.
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Executive Vice President
0
Restricted Stock Unit
2024-02-06
4
A
0
1803
0
A
Common Stock
1803
1803
D
Restricted Stock Unit
Common Stock
2123.8671
2123.8671
D
Restricted Stock Unit
Common Stock
3781.6999
3781.6999
D
Stock Option
196.14
2024-02-06
4
A
0
6936
0
A
Common Stock
6936
6936
D
Stock Option
162.07
Common Stock
7834
7834
D
Stock Option
Common Stock
39737
39737
D
Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Not applicable.
One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. The RSUs vest as follows: 2,108.6777 RSUs will vest on February 10, 2024; and 1,673.0222 RSUs will vest on February 8, 2025.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.
Each option expires on the tenth anniversary of the date of grant.
One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 8, 2023.
Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option; 6,477 options granted February 8, 2022 at an exercise price of $201.30 per option.
Each option vests on the third anniversary of the date of grant.
/s/ Lauren Luptak, as Attorney-in-Fact
2024-02-08